Back to Journals » OncoTargets and Therapy » Volume 7

Development of anaplastic lymphoma kinase (ALK) inhibitors and molecular diagnosis in ALK rearrangement-positive lung cancer

Total article views   HTML views PDF downloads Totals
16,032 Dovepress* 12,556+ 3,417 15,973
PubMed Central* 3,476 1,156 4,632
Totals 16,032 4,573 20,605
*Since 5 March 2014
+Since July 2016
Total mentioned Facebook Delicious Reddit Twitter Others
2 0 0 0 0 2

View citations on PubMed Central and Google Scholar